Medico Intercontinental Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹19.85 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.70 per cent from ₹20.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.70 per cent.
Operating Profit
Operating Profit stands at ₹1.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 280.68 per cent from ₹-0.88 crore. This corresponds to a year-on-year *(YoY) decline of 16.32 per cent.
PBDT
PBDT stands at ₹0.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 102.12 per cent from ₹-2.36 crore. This corresponds to a year-on-year *(YoY) decline of 97.27 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-1.38 crore, reflecting a quarter-on-quarter *(QoQ) increase of 67.98 per cent from ₹-4.31 crore. This corresponds to a year-on-year *(YoY) decline of 186.25 per cent.
Net Profit
Net Profit stands at ₹-1.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 63.19 per cent from ₹-4.51 crore. This represents a 241.88 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Medico Intercontinental Ltd Earnings
- YOY
- QOQ
Medico Intercontinental Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Medico Intercontinental Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Medico Intercontinental Ltd Financial Reports
Medico Intercontinental Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Medico Intercon. | -6.84% | -5.83% | -23.44% | -41.76% | -36.76% | -44.43% |
| Guj. Terce Labs. | 8.89% | 5.04% | 11.98% | -0.42% | -13.23% | -33.54% |
| Rekvina Labs | 4.70% | 9.62% | -3.52% | 79.42% | 476.27% | 476.27% |
| Shree Ganesh Bio | -1.64% | -1.64% | -10.45% | -6.25% | -13.04% | -35.48% |
| Zenlabs Ethica | 1.59% | 2.15% | 30.54% | 42.96% | -3.28% | -10.21% |
| Zenith Health | 2.47% | 5.40% | 0.91% | 0.00% | -10.51% | -28.76% |
| Parmax Pharma | 0.00% | -2.26% | 3.46% | 1.20% | -5.33% | -31.70% |
Company Info
Company Information
Managing Director : Samir Shah
Addtnl Non-Executive Director : Amar Jaiswal
Addtnl Non-Executive Director : Mitul Shah
Addtnl Non-Executive Director : Tanvi Shah
Addtnl Independent Director : Dinesh Shah